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Abstract
Background: Intramural metastasis (IM) is extremely rare in colorectal cancer, although it often occurred in
esophageal cancer.
Case Presentation: We report a rare case of T1 rectal cancer with IM which was successfully resected by laparoscopic
surgery. A 62-year-old man was admitted to our institution for the treatment of rectal cancer detected by medical
examination. Colonoscopy revealed two tumors in the rectum: a type II rectal cancer of 2 cm in diameter located 5 cm
proximal to the anal verge and a submucosal tumor of 1 cm in diameter located approximately 1.5 cm proximal to the
rectal cancer. Abdominal computed tomography (CT), magnetic resonance imaging (MRI), and transrectal
ultrasonography indicated the rectal cancer invaded into the submucosal layer with no metastasis to regional lymph
nodes or distant organs. The patient underwent laparoscopic intersphincteric resection.Histopathological analysis revealed
that the rectal cancer was moderately differentiated adenocarcinoma (stage I; pT1N0M0 according to the 7th edition of
UICC) with severe lymphovascular invasion (ly1, v3) and that the submucosal tumor was composed of moderately
differentiated adenocarcinoma proliferating within the muscularis propria. A number of features of the submucosal tumor
indicated that this was an IM of the rectal cancer: clearly distinct location from the rectal cancer, growth predominantly
within the muscularis propria, similar structural and cellular heterogeneity, and the presence of tumor emboli within
vascular vessels. The patient was postoperatively followed for more than 4 years without any sign of recurrence.
Conclusions: To the best of our knowledge, this is the first report of the T1 rectal cancer with IM.
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Background
There have been few reports of intramural metastasis
(IM) of rectal cancer, although IM has been frequently re-
ported and considered to be one of the most important
prognostic factors in esophageal cancer [1–3]. Conse-
quently, it is unclear about the clinical significance and
the treatment strategy of IM in rectal cancer. We believe
this is the first report of the T1 rectal cancer with IM.
Case presentation
A 62-year-old man was admitted to our hospital for
the treatment of rectal tumor incidentally found by
rectal examination during a routine medical checkup.
The patient had no previous history of malignancy.
Colonoscopy revealed a type II rectal tumor of 2 cm
in diameter located 5 cm proximal to the anal verge
and a submucosal tumor of 1 cm in diameter ap-
proximately 1.5 cm proximal to the rectal cancer. In
addition, a small adenomatous polyp was observed
near the rectal cancer (Fig. 1a). The biopsy of the
rectal tumor was suggestive of moderately differenti-
ated adenocarcinoma. The biopsy of the submucosal
tumor was not performed because it was thought to
be included within the region planned for surgical re-
section against the rectal cancer. Transrectal ultrason-
ography suggested the invasion depth of rectal cancer
was the deep layer of the submucosa but not the
muscularis propria (Fig. 1b). Abdominal CT showed
there was no evidence of metastasis to regional lymph
nodes or distant organs (data not shown). Barium
enema examination suggested a small tumor with an
irregular surface and a smaller submucosal tumor
with a smooth surface located at the anterior wall of
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the rectum (Fig. 1c). MRI showed that the rectal cancer
was located at the anterior wall of the rectum without in-
vasion into the prostate (Fig. 1d), and diffusion-weighted
imaging (DWI) that showed a high signal intensity was ac-
cumulated into the rectal cancer (data not shown). Results
of laboratory blood tests, including tumor markers, were
within normal ranges. Collectively, we preoperatively diag-
nosed cStage I rectal cancer and performed laparoscopic
intersphincteric resection (ISR).
Macroscopic analysis of resected specimens revealed a
16 × 15-mm type II rectal cancer with an irregular sur-
face, a 10 × 10-mm submucosal tumor located 15 mm
a b
c d
Fig. 1 a Colonoscopy revealed a primary rectal cancer (1), a submucosal tumor (2), and an adenomatous polyp (3). b Transrectal ultrasonography
showed that the invasion depth of rectal cancer was the deep layer of the submucosa but not the muscularis propria. c Barium enema
examination showed that a rectal cancer with an irregular surface (1), a submucosal tumor with a smooth surface (2), and an adenomatous
polyp (3) are located at the anterior wall of the rectum. d MRI showed that the rectal cancer was located at the anterior wall of the rectum
without invasion into the prostate
a b
Fig. 2 Resected rectal tumors. a Macroscopic findings; a 16 × 15-mm type II rectal cancer (1), a 10 × 10-mm submucosal tumor (2), and a 10 × 7-mm
adenomatous polyp (3). b Gross appearance of cross-section showed a primary rectal cancer (1), a submucosal tumor (2), and an adenomatous polyp
(3). Submucosal tumor (2) was not connected to the primary rectal cancer (1) and was located within muscularis propria
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proximal to the primary rectal cancer, and a 10 × 7-mm
adenomatous polyp located 20 mm proximal to the pri-
mary rectal cancer (Fig. 2a, b). Histopathological analysis
revealed that the primary rectal cancer was moderately
differentiated adenocarcinoma with severe lymphovascu-
lar invasion: pT1 (submucosal invasion depth 3500 μm),
pN0, pM0, ly1, v3, and pStage I. Immunohistochemical
analysis using the stainings of D2-40 and Victoria blue
was performed to evaluate lymphatic and vascular inva-
sion (Fig. 3a–c). The submucosal tumor was composed
of moderately differentiated adenocarcinoma proliferat-
ing within the muscularis propria. Moreover, numerous
tumor emboli within vascular, but not lymphatic, vessels
were observed in regions surrounding the submucosal
tumor (Fig. 3d–f ). We diagnosed the submucosal tumor
to be an IM of the primary rectal cancer based on the
following observations: (1) distinct location from the
rectal cancer, (2) the gross appearance of the submucosal
tumor without intraepithelial cancer extension, (3) the
same histological type as the primary rectal cancer, and
(4) tumor emboli within vascular vessels observed in re-
gions surrounding the submucosal tumor as well as the
primary rectal cancer. Three weeks after the operation,




Fig. 3 Histological findings (a, d H&E, ×12.5, scale bar, 1000 μm; b, e D2-40 staining, ×100, scale bar, 100 μm; c, f Victoria blue staining, ×100, scale
bar, 100 μm) a–c The primary rectal cancer was moderately differentiated adenocarcinoma with severe lymphovascular invasion: pT1 (submucosal
invasion depth 3500 μm), ly1, v3. d–f The submucosal tumor was composed of moderately differentiated adenocarcinoma proliferating within
the muscularis propria, and the tumor emboli within vascular, not lymphatic, vessels, were observed around the submucosal tumor
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of the rectal cancer was stage I, but the patient elected
to undergo adjuvant therapy because IM is one of the
poorer prognostic factors in esophageal and gastric can-
cers [1–4]. Adjuvant chemotherapy (UFT + LV) was
administered for 6 months postoperatively. The patient
has been followed for more than 4 years without any
signs of recurrence.
Discussion
IM is often observed in esophageal cancer but quite
rarely in rectal cancer. IM of the esophageal cancer was
first reported by Watson in 1933 [5], and the frequency
of IM has been reported to be about 10–15 % in ad-
vanced esophageal cancers [1–3]. The prognosis in
esophageal cancer with IM was poor because of higher
frequencies of lymph node and distant metastases [1–3].
In rectal cancer, lymphovascular invasion beyond the
primary lesion is termed to be microscopic distal intra-
mural spread (DIS). According to previous studies, DIS
occurs in 10–40 % of rectal cancer, is significantly
associated with lymph node and distant metastases, and
is a risk factor for local recurrence and poor prognosis
[6–8]. When DIS occurs, it is usually within 2.0 cm of
the tumor [6–8]. As a result, a 2-cm distal margin has
become acceptable for resection of rectal cancer. IM in
esophageal cancer has been interpreted to be caused by
lymphovascular invasion into the submucosal layer. In
the present case, histological findings demonstrated in-
vasion of the rectal cancer into the submucosal layer
(T1) with severe lymphovascular invasion, a submucosal
tumor consisting of cancer cells within the muscularis
propria, and the tumor emboli within vascular vessels
surrounding the submucosal tumor. Therefore, the
submucosal tumor was assumed to represent IM via
vascular invasion of tumor cells. To the best of our
knowledge, this is the first report of T1 rectal cancer
with IM.
The management of rectal cancer has become increas-
ingly complex. Presently, three major curative surgical
interventions are available: local excision, sphincter-
preserving surgery, and abdominoperineal resection. In-
dications for local excision that preserves anal sphincter
anatomy and function include small T1 lesions. How-
ever, the use of local excision is limited by an inability to
assess regional lymph nodes and uncertainty of onco-
logic outcome. According to guidelines issued by the
Japanese Society for Cancer of the Colon and Rectum
(JSCCR) in 2010, the criteria for identifying curable T1
colorectal cancer after endoscopic resection were well/
moderately differentiated of papillary histologic grade,
no vascular invasion, submucosal invasion depth less
than 1000 μm, and tumor budding grade 1 (low grade)
[9]. The local recurrence rate in patients with T1 rectal
cancer following resection is in the range of 4–14 %
at 5 years [10–12]. In the present case, sphincter-
preserving surgery (i.e., laparoscopic ISR) was consid-
ered to be adequate considering the distance of sub-
mucosal invasion depth and severe lymphovascular
invasion. The prognosis of esophageal cancer with IM
is exceedingly poor with a survival rate of 9 % at
5 years and a median survival time of 0.7 years [2],
which made IM one of the poor prognostic factors.
Although there is a lack of consensus regarding treat-
ment strategies, IM in rectal cancer may be a poor
prognostic factor as in esophageal cancer. In the
present case, postoperative adjuvant chemotherapy
was done due to the patient’s desire. Regarding the
strategy of rectal cancer with IM, further studies are
required to facilitate the development of treatment
strategies for rectal cancer with IM.
Conclusions
We report a case of rectal cancer with IM. IM of rectal
cancer is extremely rare; however, careful observation of
the residual rectum around the primary tumor should
be conducted, even in early rectal cancer. Preoperative
diagnosis of IM may help to decide therapeutic strategy.
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